For instance, transitional Breg from cord blood could be of benefit to mitigate chronic graft-versus-host disease after hematopoietic transplantation when using this source as opposed to bone marrow since these IL-10 B cells present a strong inhibitory capacity (63). The gene discussed is IL10; the disease is graft versus host disease.